Profile data is unavailable for this security.
About the company
Arterra Bioscience SpA is an Italy-based biotechnology company. It focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The Company collaborates with private companies, universities and research institutes all over the world.
- Revenue in EUR (TTM)3.30m
- Net income in EUR1.08m
- Incorporated--
- Employees30.00
- LocationArterra Bioscience SpAvia Benedetto Brin, 69NAPOLI 80142ItalyITA
- Websitehttps://www.arterrabio.it
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acticor Biotech SA | 0.00 | -18.65m | 12.13m | 24.00 | -- | 25.82 | -- | -- | -1.68 | -1.68 | 0.00 | 0.0298 | 0.00 | -- | -- | 0.00 | -145.59 | -- | -297.22 | -- | -- | -- | -- | -- | -- | -9.32 | 0.9504 | -- | -- | -- | -25.94 | -- | -- | -- |
| Bivictrix Therapeutics PLC | 0.00 | -3.01m | 12.19m | 10.00 | -- | 2.92 | -- | -- | -0.0351 | -0.0351 | 0.00 | 0.0429 | 0.00 | -- | -- | -- | -57.64 | -- | -65.12 | -- | -- | -- | -- | -- | -- | -- | 0.069 | -- | -- | -- | -1.92 | -- | -- | -- |
| BIOGENED SA | 23.19m | 1.24m | 12.24m | 204.00 | 9.88 | 1.39 | 5.89 | 0.5277 | 2.17 | 2.17 | 40.55 | 15.44 | 1.23 | 1.95 | 3.86 | 476,591.60 | 6.55 | 3.15 | 10.46 | 4.46 | 67.50 | 68.04 | 5.34 | 3.58 | 0.9303 | 4.17 | 0.3269 | -- | 20.02 | 18.88 | 50.74 | 34.99 | 9.88 | -- |
| Coegin Pharma AB | 0.00 | -2.49m | 12.63m | 0.00 | -- | 10.90 | -- | -- | -2.65 | -2.65 | 0.00 | 0.6403 | 0.00 | -- | -- | -- | -125.24 | -122.02 | -201.53 | -154.70 | -- | -- | -- | -28,466.75 | -- | -170.65 | 0.00 | -- | -- | -- | 20.60 | -- | -- | -- |
| Chill Brands Group PLC | 173.22k | -4.30m | 12.86m | 2.00 | -- | -- | -- | 74.24 | -0.0142 | -0.0142 | 0.0006 | -0.0024 | 0.0319 | 0.0992 | 0.3639 | 73,310.00 | -79.21 | -72.55 | -141.46 | -105.35 | 53.05 | -- | -2,485.30 | -1,625.46 | 0.6499 | -8.48 | 1.17 | -- | -86.73 | -50.89 | 23.50 | -- | -35.95 | -- |
| Vivesto AB | 0.00 | -10.38m | 12.92m | 6.00 | -- | 0.7671 | -- | -- | -0.219 | -0.219 | 0.00 | 0.352 | 0.00 | -- | -- | 0.00 | -44.08 | -- | -47.15 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | 64.80 | -- | -- | -- |
| Synairgen plc | 0.00 | -11.80m | 13.06m | 30.00 | -- | 0.6925 | -- | -- | -0.0496 | -0.0496 | 0.00 | 0.0793 | 0.00 | -- | -- | 0.00 | -41.40 | -54.75 | -48.86 | -60.72 | -- | -- | -- | -83,247.62 | -- | -- | 0.00 | -- | -- | -- | 63.74 | -- | 0.00 | -- |
| Read Gene SA | 2.50m | -336.38k | 13.12m | 11.00 | -- | 12.81 | -- | 5.24 | -0.1551 | -0.1551 | 1.07 | 0.3732 | 0.7606 | 9.91 | 9.55 | -- | -10.22 | -1.06 | -10.58 | -1.31 | 91.56 | 88.41 | -13.44 | -2.42 | 10.10 | -3.45 | 0.00 | -- | 40.14 | 16.00 | -731.53 | -- | -- | -- |
| Arterra Bioscience SpA | 3.30m | 1.08m | 13.25m | 30.00 | 12.26 | 1.23 | 7.81 | 4.01 | 0.1624 | 0.1624 | 0.4985 | 1.62 | 0.263 | 1.18 | -- | -- | 8.57 | 10.57 | 9.44 | 12.30 | 55.03 | 60.57 | 32.57 | 34.31 | 7.47 | -- | -- | -- | -7.28 | 6.36 | -23.89 | 0.6056 | -- | -- |
| NicOx SA | 3.57m | -17.36m | 13.33m | 11.00 | -- | 0.2301 | -- | 3.73 | -0.3721 | -0.3721 | 0.0753 | 0.9128 | 0.0394 | -- | 1.83 | 324,909.10 | -19.13 | -19.22 | -21.35 | -20.78 | -- | -- | -485.70 | -370.14 | -- | -- | 0.3172 | -- | -54.78 | 7.25 | 36.57 | -- | -13.35 | -- |
| Plant Advanced Technologies PAT SA | 1.68m | 79.16k | 13.97m | 27.00 | 173.91 | 1.63 | 24.10 | 8.31 | 0.0725 | 0.0725 | 1.54 | 7.73 | 0.1118 | -0.4123 | 1.60 | 62,278.52 | 0.5262 | -3.53 | 0.6534 | -4.39 | 128.03 | 134.21 | 4.71 | -33.16 | 0.4183 | -15.32 | 0.3402 | -- | 8.56 | 8.05 | 119.67 | -38.00 | -- | -- |
| AlzeCure Pharma AB | 0.00 | -3.33m | 14.01m | 11.00 | -- | 8.72 | -- | -- | -0.5685 | -0.5685 | 0.00 | 0.2122 | 0.00 | -- | -- | 0.00 | -92.80 | -52.78 | -115.25 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
| Genincode PLC | 2.55m | -8.29m | 14.37m | 36.00 | -- | 5.11 | -- | 5.63 | -0.0732 | -0.0732 | 0.0225 | 0.0135 | 0.2703 | 21.88 | 3.33 | 60,000.00 | -87.79 | -- | -124.10 | -- | 47.31 | -- | -324.81 | -- | 1.24 | -- | 0.1883 | -- | 51.05 | -- | -26.21 | -- | -- | -- |
| Mithra Pharmaceuticals SA | 40.16m | -173.50m | 14.45m | 229.00 | -- | -- | -- | 0.3599 | -2.51 | -2.51 | 0.6363 | -1.49 | 0.1102 | 0.4452 | 0.777 | -- | -47.60 | -22.24 | -70.17 | -27.69 | 45.34 | 73.13 | -432.08 | -199.11 | 0.4339 | -3.07 | 2.01 | -- | -40.06 | -7.05 | -191.01 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Mediolanum Gestione Fondi SGRpAas of 29 Dec 2023 | 72.00k | 1.08% |
| Lemanik Invest SAas of 30 Jun 2022 | 10.50k | 0.16% |
